1. An Update on the Effect of Natural Products on Oncogenic Transcription Factors in Triple Negative Breast Cancer
   Ashwathi Vijayalekha et al, 2022, Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics CrossRef
2. Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies
   Jinbao Lai et al, 2023, American Journal of Clinical Oncology CrossRef
3. Chemomodulatory Effect of the Marine-Derived Metabolite “Terrein” on the Anticancer Properties of Gemcitabine in Colorectal Cancer Cells
   Reham Khaled Abuhijjleh et al, 2023, Marine Drugs CrossRef
4. The Anticancer Potential of Maslinic Acid and Its Derivatives: A Review
   Lei Yu et al, 2021, Drug Design, Development and Therapy CrossRef
5. Drug resistance and new therapies in gallbladder cancer
   Yuxin Sun et al, 2023, Drug Discoveries & Therapeutics CrossRef
6. Advances in Research on the Preparation and Biological Activity of Maslinic Acid
   Jianqiang Deng et al, 2021, Mini-Reviews in Medicinal Chemistry CrossRef
7. Role of Pentacyclic Triterpenoid Acids in the Treatment of Bladder Cancer
   Anindita Ghosh et al, 2022, Mini-Reviews in Medicinal Chemistry CrossRef
8. 2-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells
   Immo Serbian et al, 2019, European Journal of Medicinal Chemistry CrossRef
9. Triterpene derivative improves the renal function of streptozotocin-induced diabetic rats: a follow-up study on maslinic acid
   Blessing Nkazimulo Mkhwanazi et al, 2019, Renal Failure CrossRef
10. Bioactivities and Structure‐Activity Relationships of Maslinic Acid Derivatives: A Review
    Rui Yan et al, 2024, Chemistry & Biodiversity CrossRef
11. Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells via up‐regulation of MEST through NF‐κB1
    Zhengyi Ruan et al, 2019, The FASEB Journal CrossRef
12. Maslinic acid solid lipid nanoparticles as hydrophobic anticancer drug carriers: Formulation, in vitro activity and in vivo biodistribution
    Aixa Aguilera-Garrido et al, 2023, Biomedicine & Pharmacotherapy CrossRef
13. Maslinic Acid Enhances Docetaxel Response in Human Docetaxel-Resistant Triple Negative Breast Carcinoma MDA-MB-231 Cells via Regulating MELK-FoxM1-ABCB1 Signaling Cascade
    Ke Wang et al, 2020, Frontiers in Pharmacology CrossRef
14. Maslinic Acid: A New Compound for the Treatment of Multiple Organ Diseases
    Yan He et al, 2022, Molecules CrossRef
15. Promising molecular mechanisms responsible for gemcitabine resistance in cancer
    Yanfei Jia et al, 2015, Genes & Diseases CrossRef
16. Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells
    Xiaoyu Yang et al, 2017, Redox Biology CrossRef